PBS

NCPDP Announces Emmy-Winning David Pogue to Deliver Keynote Address for Its 2024 Annual Conference "Innovation Starts Here"

Retrieved on: 
Tuesday, February 20, 2024

SCOTTSDALE, Ariz., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today that David Pogue, the Emmy Award-winning CBS Sunday Morning correspondent, NOVA host, and former New York Times columnist, will give a captivating keynote address at its 2024 Annual Technology & Business Conference, "Innovation Starts Here". The Annual Conference, which will be held May 6-8, 2024, at the Westin Kierland Resort & Spa in Scottsdale, Arizona, is expected to draw more than 700 attendees representing a broad cross-section of pharmacy and other healthcare-related industry segments.

Key Points: 
  • SCOTTSDALE, Ariz., Feb. 20, 2024 /PRNewswire-PRWeb/ -- NCPDP announced today that David Pogue, the Emmy Award-winning CBS Sunday Morning correspondent, NOVA host, and former New York Times columnist, will give a captivating keynote address at its 2024 Annual Technology & Business Conference, "Innovation Starts Here" .
  • "Mr. Pogue will bring a diverse, interdisciplinary perspective that will motivate NCPDP's Annual Conference attendees to think differently about the future of healthcare technology."
  • NCPDP's 2024 Annual Technology & Business Conference "Innovation Starts Here" is open to all healthcare industry stakeholders.
  • For real-time updates before and during the event, follow @NCPDP on X, NCPDP on LinkedIn, or join the discussion using NCPDP's 2024 Annual Technology & Business Conference hashtag: #NCPDP24.

Beloved Viral Internet Sensation "Nora the Piano Cat" Inspires Development of New Animated Series for Children Worldwide

Retrieved on: 
Thursday, February 15, 2024

PHILADELPHIA, Feb. 15, 2024 /PRNewswire/ -- Today, All That's Good Productions unveils an official sizzle reel for Nora the Piano Cat, a creative, culturally diverse, and educational animated children's series for all ages, inspired by "one of Philadelphia's first viral animal stars", Nora the Piano Cat. The show stars Nora, who first became globally recognized in 2007 as a musically gifted internet sensation after a YouTube video of her playing the piano went viral. Nora has been featured on BBC Earth, TODAY.com, The Los Angeles Times, USA Today, 6ABC Action News, The Philadelphia Inquirer, Hong Kong's My Pet magazine, National Geographic, and more.

Key Points: 
  • The show stars Nora, who first became globally recognized in 2007 as a musically gifted internet sensation after a YouTube video of her playing the piano went viral.
  • Despite this loss, her memory endures through the music and joy she brought to her devoted global fanbase.
  • "I did not adopt Nora the Piano Cat, she adopted me," says Nora's owner Betsy Alexander.
  • This new series, produced in Nora's hometown of Philadelphia, aims to enrich global audiences by showcasing diverse music genres.

The Kelley Group Announces Launch of the Financial Industry's First Leadership Black African American Coalition

Retrieved on: 
Thursday, February 15, 2024

The BAAC membership lends support for the betterment of Black leaders, their firms and the entire financial industry.

Key Points: 
  • The BAAC membership lends support for the betterment of Black leaders, their firms and the entire financial industry.
  • Sarano and Brooke Kelley, co-founders of The Kelley Group and members of the Forbes Coaches Council, are hosting this event.
  • Attendance at the event is "invitation only" and is limited to managers and leaders of financial services firms.
  • The Kelley Group is a leading provider of coaching and training for North America's financial professionals.

Beloved Viral Internet Sensation "Nora the Piano Cat" Inspires Development of New Animated Series for Children Worldwide

Retrieved on: 
Thursday, February 15, 2024

PHILADELPHIA, Feb. 15, 2024 /PRNewswire/ -- Today, All That's Good Productions unveils an official sizzle reel for Nora the Piano Cat, a creative, culturally diverse, and educational animated children's series for all ages, inspired by "one of Philadelphia's first viral animal stars", Nora the Piano Cat. The show stars Nora, who first became globally recognized in 2007 as a musically gifted internet sensation after a YouTube video of her playing the piano went viral. Nora has been featured on BBC Earth, TODAY.com, The Los Angeles Times, USA Today, 6ABC Action News, The Philadelphia Inquirer, Hong Kong's My Pet magazine, National Geographic, and more.

Key Points: 
  • The show stars Nora, who first became globally recognized in 2007 as a musically gifted internet sensation after a YouTube video of her playing the piano went viral.
  • Despite this loss, her memory endures through the music and joy she brought to her devoted global fanbase.
  • "I did not adopt Nora the Piano Cat, she adopted me," says Nora's owner Betsy Alexander.
  • This new series, produced in Nora's hometown of Philadelphia, aims to enrich global audiences by showcasing diverse music genres.

Senior Whole Health by Molina Healthcare Invests $500,000 in Place-Based Supports to Reduce Health Disparities for Seniors in Massachusetts Affordable Housing Sites

Retrieved on: 
Wednesday, February 14, 2024

Senior Whole Health by Molina Healthcare (“Senior Whole Health”) in collaboration with The MolinaCares Accord (“MolinaCares”) is announcing a $500,000 investment in organizations providing place-based supports (PBS) for residents of senior affordable housing sites.

Key Points: 
  • Senior Whole Health by Molina Healthcare (“Senior Whole Health”) in collaboration with The MolinaCares Accord (“MolinaCares”) is announcing a $500,000 investment in organizations providing place-based supports (PBS) for residents of senior affordable housing sites.
  • The resources will enhance care and wellness for facility residents across greater Boston.
  • It leverages on-site resident service coordinators (RSCs) who help seniors access health care providers, health plans, and community organizations.
  • “Improving health outcomes for older adults in Massachusetts goes beyond providing traditional medical services,” said Bill Graham, plan president for Senior Whole Health by Molina Healthcare.

Just Published: 'MAGA Republicans Are Already Normal -- And Other Shocking Notions'

Retrieved on: 
Tuesday, February 13, 2024

CINCINNATI, Feb. 13, 2024 /PRNewswire-PRWeb/ -- Former Washington Post contributing columnist Gary Abernathy's new book, "MAGA Republicans Are Already Normal – And Other Shocking Notions," is now available in hardcover, paperback and eBook on Amazon.

Key Points: 
  • CINCINNATI, Feb. 13, 2024 /PRNewswire-PRWeb/ -- Former Washington Post contributing columnist Gary Abernathy's new book, "MAGA Republicans Are Already Normal – And Other Shocking Notions," is now available in hardcover, paperback and eBook on Amazon.
  • He predicted early in the process that the billionaire businessman and reality TV star would win the GOP presidential nomination.
  • Throughout the campaign and in the months following Trump's historic upset victory, Abernathy continued writing about Trump.
  • "MAGA Republicans Are Already Normal" opens with a collection of the columns written for the Times-Gazette that caught the attention of the Post.

PBS ANNOUNCES NEW PROGRAMMING AT WINTER 2024 TCA PRESS TOUR

Retrieved on: 
Monday, February 12, 2024

ET (check local listings) on PBS, PBS.org , and the PBS App .

Key Points: 
  • ET (check local listings) on PBS, PBS.org , and the PBS App .
  • The film, which explores the life and work of the 15th century polymath Leonardo da Vinci, is Burns's first non-American subject.
  • Starring Tony Award winner Leslie Odom, Jr., GREAT PERFORMANCES "Purlie Victorious" premieres Friday, May 24 at 9 p.m. on PBS ( check local listings ), on pbs.org/gperf , and the PBS App .
  • PBS KIDS is also in development with TIME Studios on a live-action shorts series supporting civic engagement through media literacy.

The New York Amsterdam News Continues Growing and Welcomes Aaron Foley as News Editor

Retrieved on: 
Monday, February 12, 2024

HARLEM, N.Y., Feb. 12, 2024 /PRNewswire/ -- The New York Amsterdam News (AmNews), one of America's oldest and most influential Black newspapers continues its unfolding renaissance with the hiring of distinguished journalist and author Aaron Foley as our new News Editor.

Key Points: 
  • HARLEM, N.Y., Feb. 12, 2024 /PRNewswire/ -- The New York Amsterdam News (AmNews), one of America's oldest and most influential Black newspapers continues its unfolding renaissance with the hiring of distinguished journalist and author Aaron Foley as our new News Editor.
  • In his new role, Foley will be instrumental in directing our news coverage and helping to transform our print and digital products.
  • Reyes will retain oversight of the paper's Blacklight investigative unit of which he is the founding editor.
  • "These two exceptional journalists will continue the work of serving our readership and creating award winning journalism," she added.

Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab

Retrieved on: 
Friday, February 9, 2024

BENGALURU, India, Feb. 8, 2024 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced a five-year partnership with Sandoz AG ('Sandoz') which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million1) and biosimilar Bevacizumab (market value of AUD$45 million2) in Australia.

Key Points: 
  • BENGALURU, India, Feb. 8, 2024 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced a five-year partnership with Sandoz AG ('Sandoz') which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million1) and biosimilar Bevacizumab (market value of AUD$45 million2) in Australia.
  • Under the agreement, Sandoz will distribute the Biocon Biologics' brands, OGIVRI® (bTrastuzumab) and ABEVMY® (bBevacizumab), and facilitate the sustained access of these medications that were previously distributed by another pharmaceutical company to patients in Australia.
  • Trastuzumab is a biosimilar of Herceptin® and Bevacizumab is a biosimilar of Avastin®3 – both biosimilars are available on the PBS and utilised for the treatment of various cancers.
  • OGIVRI® and ABEVMY® are registered trademarks of Biosimilars Newco Limited, a Biocon Biologics Company.

Biocon Biologics Partners with Sandoz Australia for Biosimilars Trastuzumab and Bevacizumab

Retrieved on: 
Friday, February 9, 2024

BENGALURU, India, Feb. 8, 2024 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced a five-year partnership with Sandoz AG ('Sandoz') which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million1) and biosimilar Bevacizumab (market value of AUD$45 million2) in Australia.

Key Points: 
  • BENGALURU, India, Feb. 8, 2024 /PRNewswire/ -- Biocon Biologics Ltd (BBL), a fully integrated biosimilars company and subsidiary of Biocon Ltd (BSE code: 532523, NSE: BIOCON), today announced a five-year partnership with Sandoz AG ('Sandoz') which provides Sandoz the exclusive rights to promote, sell and distribute biosimilar Trastuzumab (market value of AUD$35 million1) and biosimilar Bevacizumab (market value of AUD$45 million2) in Australia.
  • Under the agreement, Sandoz will distribute the Biocon Biologics' brands, OGIVRI® (bTrastuzumab) and ABEVMY® (bBevacizumab), and facilitate the sustained access of these medications that were previously distributed by another pharmaceutical company to patients in Australia.
  • Trastuzumab is a biosimilar of Herceptin® and Bevacizumab is a biosimilar of Avastin®3 – both biosimilars are available on the PBS and utilised for the treatment of various cancers.
  • OGIVRI® and ABEVMY® are registered trademarks of Biosimilars Newco Limited, a Biocon Biologics Company.